Accuray - There's Value If Linac Sales Accelerate, But That's A Big 'If'

The wait for real acceleration in revenue at Accuray (NASDAQ: ARAY ) increasingly feels like Waiting for Godot, as the company has been trying to sell investors on the China opportunity for years, and yet material revenue accelerationAnalyst’s Disclosure: I/we have a beneficial long position in the shares of ARAY either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). ...